Yuet L. Ching
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Exploring the efficacy and safety of Yu-Ping-Feng powder with variation against allergic rhinitis: a randomized, double-blind, placebo-controlled trial.
Journal: Chinese medicine
Published: January 27, 2025
Data driven identification and classification of Chinese medicine syndrome types among functional dyspepsia patients: latent tree analysis (abridged secondary publication).
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: October 10, 2024
Evaluation of Cost-Effectiveness of a Virtual Multidisciplinary Stroke Care Clinic for Community-Dwelling Survivors of Stroke.
Journal: Journal of the American Heart Association
Published: August 27, 2024
Virtual multidisciplinary stroke care clinic for community-dwelling stroke survivors: a randomised controlled trial (abridged secondary publication).
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: July 04, 2024
Faecal microbiota transplantation for patients with irritable bowel syndrome: abridged secondary publication.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: February 27, 2024
Can a microbiota-derived health supplement mitigate adverse events after COVID-19 vaccination in children?
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: November 30, 2023
A novel infant microbiome formula (SIM03) improved eczema severity and quality of life in preschool children.
Journal: Scientific reports
Published: September 14, 2023
Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: July 06, 2023
The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial.
Journal: Frontiers in pharmacology
Published: October 17, 2022
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)-A double-blind, randomized, and placebo-controlled clinical trial protocol.
Journal: Frontiers in medicine
Published: July 10, 2022
Efficacy and safety of modified Xiao-Feng Powder in the treatment of chronic urticaria: protocol of a randomized double-blind placebo-controlled study.
Journal: Chinese medicine
Published: April 07, 2022
Last Updated: 09/26/2026